Yoseph Shaaltiel
2019
In 2019, Yoseph Shaaltiel earned a total compensation of $468.3K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 8% increase compared to previous year.
Compensation breakdown
| Option Awards | $94,012 |
|---|---|
| Salary | $290,926 |
| Other | $83,383 |
| Total | $468,321 |
Shaaltiel received $290.9K in salary, accounting for 62% of the total pay in 2019.
Shaaltiel also received $94K in option awards and $83.4K in other compensation.
Rankings
In 2019, Yoseph Shaaltiel's compensation ranked 11,944th out of 13,971 executives tracked by ExecPay. In other words, Shaaltiel earned more than 14.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,944 out of 13,971 | 15th |
Division Manufacturing | 4,838 out of 5,695 | 15th |
Major group Chemicals And Allied Products | 1,907 out of 2,194 | 13th |
Industry group Drugs | 1,644 out of 1,880 | 13th |
Industry Biological Products, Except Diagnostic Substances | 352 out of 389 | 10th |
Source: SEC filing on April 15, 2020.
Shaaltiel's colleagues
We found six more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2019.
2019
Moshe Manor
Protalix BioTherapeutics
Chief Executive Officer
2019
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2019
Dror Bashan
Protalix BioTherapeutics
Chief Executive Officer
2019
Yaron Naos
Protalix BioTherapeutics
Senior Vice President, Operations
2019
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2019
Eyal Rubin
Protalix BioTherapeutics